Pfizer/BNTX Covid vaccine demonstrated 90% efficacy just reported in phase 3. Just reported on

[still_one]

Bloomberg

https://finance.yahoo.com/news/pfizer-biontech-covid-19-vaccine-114500360.html

https://finance.yahoo.com/news/pfizer-biontech-announce-vaccine-candidate-114500713.html

[NutmegYankee]

1. Awesome!

[Native]

2. 90% is extraordinary

[underpants]

3. ✅

👍

[soothsayer]

4. Did they actually try to infect people?

[Tanuki]

8. No. None of the studies in the U.S. would do that.

[soothsayer]

11. Press release, not peer reviewed journal. We shall see

[uponit7771]

16. +1, this is being done for stock bumps not for true science. I'm so sick of these press releases tha

... that have so many caveats post release of peer reviewed data that the sell of insider stock is timed to.

This is so screwed up and doesn't help people feel good about the vaccine, its too attached to politics and money

[uponit7771]

15. +1

[OnDoutside]

5. Oh no ! It's going to magically disappear !

Good news though....

[boston bean]

6. Very nice news. Keep safe still!

[still_one]

7. Absolutely. The vaccine won't be available to the general public until next year, if the safety and

results are confirmed, and the distribution is a huge task

The vaccine storage needs to be at extremely cold temperatures, and requires two dose 28 days apart

Masks and social distancing will need to be followed for at least into the third quarter of next year

[Roland99]

9. Pfizer says they could have 50 million doses by year end. Requires 2 doses

https://www.bbc.co.uk/news/amp/health-54873105

The companies plan to apply for emergency approval to use the vaccine by the end of the month.

...

Two doses, three weeks apart, are needed. The trials - in US, Germany, Brazil, Argentina, South Africa and Turkey - show 90% protection is achieved seven days after the second dose.

Pfizer believes it will be able to supply 50 million doses by the end of this year, and around 1.3 billion by the end of 2021.

However there are logistical challenges, as the vaccine has to be kept in ultra-cold storage at below minus 80C.

[Roland99]

12. ALSO, this was NOT funded by Operation Warp Speed

Link to tweet

[soothsayer]

10. "The data released by Pfizer Monday was delivered in a news release, not a peer-reviewe

Link to tweet

?s=21


Matt Ortile 🇵🇭
@ortile
·
Nov 9, 2020
"The data released by Pfizer Monday was delivered in a news release, not a peer-reviewed medical journal. It is not conclusive evidence that the vaccine is safe and effective, and the initial finding of more than 90 percent efficacy could change as the trial goes on."

Dr. Harold Henrison C. Chiu
@88DoubleDragon
Will await the published results of this phase 3 trial

[still_one]

13. I would not bet against it. The biggest challenge will be storage, production, and

distribution

[soothsayer]

14. I'm all for it! But we've seen this kind of thing before

Just bears watching (for instance, if the bigwigs cash in their stock).

Still, here’s hoping it’s legit.

[still_one]

17. All I am saying it wasn't the company who validated this data, but an independent agent

The other outstanding question is how long it would it remain effective